PubMed
Intranasal oxytocin in humans: a review of neurobiological and behavioral effects
Striepens et al., 2013
Pitocin / Love Hormone
Oxytocin is an FDA-approved 9-amino acid neuropeptide hormone naturally produced in the hypothalamus and released by the posterior pituitary. FDA-approved as Pitocin for labor induction and postpartum hemorrhage. Extensively researched for social bonding, trust, autism spectrum disorder, PTSD, anxiety, and metabolic effects. Intranasal oxytocin is widely studied; availability through compounding pharmacies and telehealth.
Overall check-ins
Trackers & reports
Overview
Oxytocin is an FDA-approved 9-amino acid neuropeptide hormone naturally produced in the hypothalamus and released by the posterior pituitary. FDA-approved as Pitocin for labor induction and postpartum hemorrhage. Extensively researched for social bonding, trust, autism spectrum disorder, PTSD, anxiety, and metabolic effects. Intranasal oxytocin is widely studied; availability through compounding pharmacies and telehealth.
Community
From check-in ratings — separate from side effects logged below. Side effects are logged separately from overall experience. A favorable check-in can still include nausea, fatigue, or injection-site reactions.
Favorable 2% · Mixed 98% · Unfavorable overall 0%
Benefits users selected when logging a favorable or mixed check-in.
Side effects are logged separately from overall experience. A favorable check-in can still include nausea, fatigue, or injection-site reactions.
Median bucket: 25–50 mcg · Most common: 25–50 mcg
Reports span 0–400 mcg
Anonymized self-reports from PeptIQ users — not prescribing guidance. Buckets group similar logged amounts; open-ended top buckets mean “at least” that dose.
Among repeat reporters, 89% said they felt similar to their last entry, 11% more positive, and 0% more negative.
Overall, repeat reporters leaned more positive than their previous entry.
Median gap between entries: 175 days · Based on 27 repeat reporters
Research
PubMed
Striepens et al., 2013
FDA Drug Label
Par, 2014
PubMed
Heinrichs et al., 2003
PubMed
Yin et al., 2024
Tools
More ways to learn about Oxytocin from observational PeptIQ data.
Related peptides
Help
This page summarizes 30 anonymized self-reports from PeptIQ users who track Oxytocin, including commonly reported effects and co-tracked peptides. These are observational patterns, not clinical outcomes.
PeptIQ separates overall check-in ratings (favorable, mixed, or unfavorable) from logged side effects like nausea or fatigue. Users often report benefits and side effects in the same check-in — a high experience score does not mean zero side effects were noted.
4 sources are linked on this page, including PubMed articles, clinical trial registries, and FDA labels where applicable. Citations describe published research — not recommendations.
This wiki does not assess safety or recommend use. Oxytocin is listed as FDA Approved. Consult a licensed clinician for personal medical decisions.
This wiki summarizes observational community reports and linked citations for Oxytocin. It does not assert therapeutic benefits. See the cited research list on this page and the educational profile for Oxytocin for study-level context — not medical advice.
Oxytocin is listed in PeptIQ as FDA Approved. Regulatory status varies by jurisdiction and can change. This wiki does not provide legal advice; check current FDA and local rules and talk with a licensed clinician or counsel for personal decisions.
Safety data quality for Oxytocin varies widely by compound and study design. PeptIQ does not establish a risk profile here. Review primary literature, product labeling where applicable, and clinician guidance. Community self-reports are not a substitute for clinical evidence.
This page links 4 indexed sources for Oxytocin. Evidence maturity differs by application — some peptides have large human programs, others are mostly preclinical. Treat citation counts as literature volume, not proof of efficacy.